Prof. Sven Bölte & the EUNETHYDIS Network

ADHD Europe are pleased to broadcast this information to the public. Professor Sven Bölte has been elected the president of UKAAN from January 2024, and is one of the collaborators in the R2D2 - Mental Health Horizon 2020 projects that ADHD Europe is involved in.
UKAAN www.ukaan.org/
R2D2 Project adhdeurope.eu/r2d2-mh-project/
About the speaker - Sven Bölte Professor of Child & Adolescent Psychiatric Science, PhD - Head of Neuropsychiatry Division, Director of the Center for Neurodevelopmental Disorders at Karolinska Institutet (KIND) - Center for Psychiatry Research, Dept. of Women's & Children's Health - Child and Adolescent Psychiatry Stockholm. He has various national and international commissions, for example he is a visiting professor at the Central Institute of Mental Health, University of Heidelberg, research associate at Curtin University in Perth (Autism Research Group), founder of the Scientific Society Autism Spectrum, editor of Child and Adolescent Psychiatry and Mental Health, and editor in chief of the Scandinavian Journal of Child Psychiatry and Psychology. He is an international ADOS-2 and ADI-R trainer, board member of Autism Sweden and Education Science at the Swedish Research Council. I have received several recognitions, such as the “Life Watch Nordiska Priset”, “Årets Ljus” (Society Attention), “Fellow of the International Society for Autism Research” (INSAR), and Psynkpriset GNET (Swedish Municipalities and Regions). Publishing more than 500 original articles, reviews, book chapters, assessment and intervention tools in the field of autism spectrum, ADHD, other neurodevelopmental conditions and mental health, which have been cited more than 31,000 times (H-index 83)''
More about EUNETHYDIS which is a network of scientists (animal and human research), clinicians and clinical researchers, cardiologists, pharmacologists and neuroscientists dedicated to the study and treatment of children with Attention Deficit Hyperactivity Disorder (ADHD) or Hyperkinesis. The European ADHD Guidelines Group is a part of EUNETHYDIS set up to serve “the provision of evidence based clinical recommendations”. It therefore seeks to apply reliable scientific knowledge to help decision-makers, service users and practitioners in making well-informed judgments about how to improve the management of people affected by ADHD. This over-riding goal involves making reviews, recommendations and guidelines, and identifying gaps in the science base. It does so, in the general spirit of EUNETHYDIS, by acting as a co-operative group of scientific and clinical disciplines, where knowledge is disseminated in an atmosphere of trust, loyalty, and mutual respect. It will maintain high ethical standards in its activities. eunethydis.eu/ eunethydis.eu/